Skip to main content
OpenTrials
Completed

NCT Number: NCT04395534

Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision

The study aim to investigate the value of the current definition of microradical resection margin in colon cancer. Is the distance from tumor tissue to resection margin and the site of any clinically prognostic importance if complete mesocolic excision has been performed.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing elective curative intended complete mesocolic excision for primary colon adenocarcinoma at Nordsjællands Hospital in Hillerød, Denmark
  • International Union Against Cancer (Union Internationale Contre le Cancer - UICC) stage III - pT1-4, pN1-2 cM0 (gastroepiploic and infrapyloric lymph node metastases are not considered as distant metastases)
  • Resident in Denmark at the time of surgery.

Exclusion criteria

  • Patients who did not undergo macroradical resections
  • Synchronous colorectal cancer
  • Venous invasion at central venous ligation.

Treatment and study plan

Complete mesocolic excision

Procedure

Primary outcomes

  1. Recurrence

    Time frame: 3 years

    Any type of recurrence

Sponsors and collaborators

Lead sponsor

Claus Anders Bertelsen, PhD, MD

Other

Registry information

Official study title

Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision: a Prospective Cohort Study

Important dates

Study start
2008
Primary completion
2020
Study completion
2020
First posted
May 20, 2020
Registry last updated
May 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.